Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.
第一作者:
Anbok,Lee
第一单位:
Department of Surgery, Busan Paik Hospital, College of Medicine, Inje University, Busan 47392, Republic of Korea.
作者:
主题词
吖啶黄(Acriflavine);苯胺化合物(Aniline Compounds);细胞系, 肿瘤(Cell Line, Tumor);减量调节(Down-Regulation);复方合剂(Drug Combinations);胶质母细胞瘤(Glioblastoma);人类(Humans);磺胺类(Sulfonamides)
DOI
10.3892/ijo.2021.5292
PMID
34913076
发布时间
2022-03-14
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文